Last $0.0070 USD
Change Today 0.00 / 0.00%
Volume 750.0
LTUS On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for lotus pharmaceuticals inc (LTUS)

Year over year, Lotus Pharmaceuticals, Inc. has seen their bottom line shrink from $16.4M USD to $14.4M USD despite an increase in revenues from $56.5M USD to $72.7M USD. An increase in the percentage of sales devoted to SGA costs from 20.77% to 25.32% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2007
Reclassified
Dec 31
2008
Restated
Dec 31
2009
Reclassified
Dec 31
2010
4 Year
Trend
Revenues45.168.156.572.7
Other Revenues11.85.7----
TOTAL REVENUES56.973.856.572.7
Cost of Goods Sold33.740.725.132.9
GROSS PROFIT23.233.231.439.8
Selling General & Admin Expenses, Total9.516.911.718.4
R&D Expenses2.41.2--0.1
OTHER OPERATING EXPENSES, TOTAL11.918.111.718.5
OPERATING INCOME11.315.119.721.3
Interest Expense-2.2-2.3-2.6-0.7
Interest and Investment Income0.10.00.00.0
NET INTEREST EXPENSE-2.1-2.3-2.5-0.7
Other Non-Operating Income (Expenses)----1.30.8
EBT, EXCLUDING UNUSUAL ITEMS9.212.818.521.4
Other Unusual Items, Total2.10.0-1.7-6.8
Other Unusual Items2.10.0----
EBT, INCLUDING UNUSUAL ITEMS11.212.816.814.6
Income Tax Expense----0.40.2
Earnings from Continuing Operations11.212.816.414.4
NET INCOME11.212.816.414.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS11.212.816.414.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS11.212.816.414.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LTUS:US $0.01 USD 0.00

LTUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LTUS.
View Industry Companies
 

Industry Analysis

LTUS

Industry Average

Valuation LTUS Industry Range
Price/Earnings 0.1x
Price/Sales 0.0x
Price/Book 0.0x
Price/Cash Flow 0.1x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LOTUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.